Live news related to GENFIT stock (FR0004163111): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Genfit published its first half 2026 results on September 28, 2026, marked by cash reserves of €113.8 million and strong growth in royalties from Iqir…
The Lille-based biotech specializing in hepatic and metabolic diseases posts the most marked recovery on the SBF 120 this Monday morning, after severa…
The Lille-based biotech company specializing in hepatic and metabolic diseases continues its correction this Friday morning, consolidating a particula…
The Lille-based biotech specializing in hepatic and metabolic diseases emerges as the worst-performing value in the SBF 120 this Thursday morning, ext…
Genfit is accumulating losses at the start of trading, establishing itself as the worst-performing value on the SBF 120 this Tuesday morning. The decl…
The Lille-based biopharma company is experiencing a sharp setback at the start of the week, despite the stock having posted several positive catalysts…
After acquiring nangibotide during summer 2026, Genfit plans to evaluate this drug candidate in acute-on-chronic liver failure (ACLF).The Lille-based …
The Scientific Index Council of Euronext Paris has decided to admit the Lille-based biopharmaceutical company to two of its indices following the annu…
The biopharmaceutical company based in Loos will participate in an American investor meeting dedicated to life sciences stocks. An opportunity for its…
The biopharmaceutical company Genfit will organize a virtual event bringing together a key opinion leader to present its non-invasive diagnostic platf…